Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia

Clinical trial NCT00108758 · COMPLETED

Trial details

NCT number: NCT00108758
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Congenital Bleeding Disorder Haemophilia A With Inhibitors Haemophilia B With Inhibitors

Start date: 2004-03-01
Primary completion: 2005-11-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.